Q3FY25 EARNING CALENDAR: AMBUJACEM, BAJAJFINANCE, MARUTI, SRF, TATAMOTORS, VOLTAS, RAYMOND, MASFIN
AHMEDABAD, 29 JANUARY:
| 29.01.2025 | AARTIDRUGS, ABDL, ACMESOLAR, ADANIPOWER, AMBUJACEM, ARVSMART, ASAHIINDIA, ASKAUTOLTD, BAJFINANCE, BANSALWIRE, BLUEDART, BLUEJET, BLUESTARCO, BRIGADE, CAMS, CARTRADE, CHALET, CHOICEIN, CRAFTSMAN, DATAMATICS, DEEPAKFERT, ECLERX, FILATEX, FINOPB, FLUOROCHEM, GABRIEL, IMFA, INDIANB, JBMA, JKPAPER, JSL, JWL, KPITTECH, MARUTI, MASFIN, OLECTRA, ONESOURCE, ORIENTELEC, POWERINDIA, QUESS, RADICO, RAMRAT, RANEENGINE, RAYMOND, RBA, SAMHI, SMCGLOBAL, SRF, TATAMOTORS, TEAMLEASE, TMB, USHAMART, VAIBHAVGBL, VOLTAS, VSSL, WEL, WESTLIFE |
AMBUJACEM YoY
Revenue expected at Rs 8510 crore versus Rs 8128 crore
EBITDA expected to be seen at Rs 1483 crore versus Rs 1732 crore
EBITDA margin expected to be seen at 17.43% versus 21.31%
Net profit expected to be seen at Rs 762 crore versus Rs 823 crore
BAJFINANCE YoY
NII expected at Rs 10381 crore versus Rs 7655 crore
EBIT expected to be seen at Rs 7436 crore versus Rs 6143 crore
EBIT margin expected to be seen at 59.12% versus 66.06%
Net profit expected to be seen at Rs 4127 crore versus Rs 3639 crore
MARUTI YoY
Revenue expected at Rs 38726 crore versus Rs 33308 crore
EBITDA expected to be seen at Rs 4498 crore versus Rs 3907 crore
EBITDA margin expected to be seen at 11.61% versus 11.73%
Net profit expected to be seen at Rs 3687 crore versus Rs 3130 crore
SRF YoY
Revenue expected at Rs 3387 crore versus Rs 3053 crore
EBITDA expected to be seen at Rs 565 crore versus Rs 565 crore
EBITDA margin expected to be seen at 16.68% versus 18.53%
Net profit expected to be seen at Rs 223 crore versus Rs 253 crore
TATAMOTORS YoY
Revenue expected at Rs 116912 crore versus Rs 110577 crore
EBITDA expected to be seen at Rs 15772 crore versus Rs 15418 crore
EBITDA margin expected to be seen at 13.90% versus 13.94%
Net profit expected to be seen at Rs 6643 crore versus Rs 7113 crore
VOLTAS QoQ
Revenue expected at Rs 3024 crore versus Rs 2619 crore
EBITDA expected to be seen at Rs 205 crore versus Rs 162 crore
EBITDA margin expected to be seen at 6.78% versus 6.19%
Net profit expected to be seen at Rs 157 crore versus Rs 134 crore
| 30.01.2025 | AAVAS, ADANIENT, ADANIPORTS, AJANTPHARM, ASTRAL, AVL,BAJAJFINSV, BAJAJHLDNG, BANKBARODA, BEL, BIOCON, CARERATING, CHEMFAB, CLEAN, COROMANDEL, DABUR, DEEPINDS, DODLA, ELCIDIN, GAIL, GREENLAM, HAWKINCOOK, HEIDELBERG, HESTERBIO, INDGN, JINDALSTEL, JISLJALEQS, JITFINFRA, JTEKTINDIA, JYOTIRES, KALYANKJIL, LALPATHLAB, LT, MANYAVAR, MAXHEALTH, MOSCHIP, NAVINFLUOR, NESCO, PARAGMILK, PAUSHAKLTD, PHOENIXLTD, POKARNA, POLICYBZR, PRAJIND, PRESTIGE, PRICOLLTD, PROTEAN, RAYMONDLSL, SHANTIGEAR, SHILCTECH, SHREECEM, SJS, STAR, STARCEMENT, STYRENIX, SUBROS, VOLTAMP, WAAREEENER, WELSPUNLIV |
ADANIENT YoY
Revenue expected at Rs 29727 crore versus Rs 28336 crore
EBITDA expected to be seen at Rs 5509 crore versus Rs 3227 crore
EBITDA margin expected to be seen at 18.53% versus 11.39%
Net profit expected to be seen at Rs 1719 crore versus Rs 1888 crore
ADANIPORTS YoY
Revenue expected at Rs 7232 crore versus Rs 6920 crore
EBITDA expected to be seen at Rs 4443 crore versus Rs 4293 crore
EBITDA margin expected to be seen at 61.44% versus 62.04%
Net profit expected to be seen at Rs 2632 crore versus Rs 2208 crore
ASTRAL YoY
Revenue expected at Rs 1500 crore versus Rs 1370 crore
EBITDA expected to be seen at Rs 230 crore versus Rs 205 crore
EBITDA margin expected to be seen at 15.33% versus 14.97%
Net profit expected to be seen at Rs 129 crore versus Rs 113 crore
BAJAJFINASV QoQ
Revenue expected at Rs 30357 crore versus Rs 33703 crore
EBIT expected to be seen at Rs 5953 crore versus Rs 12011 crore
EBIT margin expected to be seen at 19.61% versus 35.64%
BANKBARODA YoY
NII expected at Rs 11973 crore versus Rs 11101 crore
EBIT expected to be seen at Rs 7783 crore versus Rs 6348 crore
EBIT margin expected to be seen at 55.95% versus 45.64%
Net profit expected to be seen at Rs 4495 crore versus Rs 4579 crore
BEL YoY
Revenue expected at Rs 4850 crore versus Rs 4142 crore
EBITDA expected to be seen at Rs 1176 crore versus Rs 1072 crore
EBITDA margin expected to be seen at 24.25% versus 25.89%
Net profit expected to be seen at Rs 946 crore versus Rs 859 crore
BIOCON YoY
Revenue expected at Rs 3923 crore versus Rs 3953 crore
EBITDA expected to be seen at Rs 840 crore versus Rs 926 crore
EBITDA margin expected to be seen at 21.41% versus 23.44%
Net profit expected to be seen at Rs 153 crore versus Rs 638 crore
COROMANDEL YoY
Revenue expected at Rs 6213 crore versus Rs 5464 crore
EBITDA expected to be seen at Rs 667 crore versus Rs 357 crore
EBITDA margin expected to be seen at 10.74% versus 6.54%
Net profit expected to be seen at Rs 423 crore versus Rs 213 crore
DABUR YoY
Revenue expected at Rs 3349 crore versus Rs 3255 crore
EBITDA expected to be seen at Rs 666 crore versus Rs 667 crore
EBITDA margin expected to be seen at 19.87% versus 20.52%
Net profit expected to be seen at Rs 507 crore versus Rs 514 crore
MAXHEALTH YoY
Revenue expected at Rs 2148 crore versus Rs 1335 crore
EBITDA expected to be seen at Rs 563 crore versus Rs 386 crore
EBITDA margin expected to be seen at 26.21% versus 28.90%
Net profit expected to be seen at Rs 362 crore versus Rs 289 crore
NAVINFLUOR YoY
Revenue expected at Rs 585 crore versus Rs 513 crore
EBITDA expected to be seen at Rs 129 crore versus Rs 127 crore
EBITDA margin expected to be seen at 22.05% versus 24.88%
Net profit expected to be seen at Rs 71 crore versus Rs 25 crore
PRESTIGE YoY
Revenue expected at Rs 2352 crore versus Rs 1795 crore
EBITDA expected to be seen at Rs 784 crore versus Rs 551 crore
EBITDA margin expected to be seen at 33.33% versus 30.71%
Net profit expected to be seen at Rs 197 crore versus Rs 116 crore
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)
